DD224033A5 - Verfahren zur herstellung substituierter 1,2,4-triazine und deren salze - Google Patents

Verfahren zur herstellung substituierter 1,2,4-triazine und deren salze Download PDF

Info

Publication number
DD224033A5
DD224033A5 DD84268757A DD26875784A DD224033A5 DD 224033 A5 DD224033 A5 DD 224033A5 DD 84268757 A DD84268757 A DD 84268757A DD 26875784 A DD26875784 A DD 26875784A DD 224033 A5 DD224033 A5 DD 224033A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
compound
group
amino
item
Prior art date
Application number
DD84268757A
Other languages
German (de)
English (en)
Inventor
Geoffrey Allan
Alistair A Miller
David A Sawyer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DD224033A5 publication Critical patent/DD224033A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD84268757A 1983-10-27 1984-10-26 Verfahren zur herstellung substituierter 1,2,4-triazine und deren salze DD224033A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328757A GB8328757D0 (en) 1983-10-27 1983-10-27 Chemical compounds

Publications (1)

Publication Number Publication Date
DD224033A5 true DD224033A5 (de) 1985-06-26

Family

ID=10550834

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84268757A DD224033A5 (de) 1983-10-27 1984-10-26 Verfahren zur herstellung substituierter 1,2,4-triazine und deren salze

Country Status (21)

Country Link
US (1) US4649139A (ru)
EP (1) EP0142306A3 (ru)
JP (1) JPS60109577A (ru)
KR (1) KR890000991B1 (ru)
AU (1) AU564667B2 (ru)
CA (1) CA1261328A (ru)
DD (1) DD224033A5 (ru)
DK (1) DK512184A (ru)
ES (1) ES8606304A1 (ru)
FI (1) FI844212L (ru)
GB (1) GB8328757D0 (ru)
GR (1) GR80723B (ru)
HU (1) HU191566B (ru)
IL (1) IL73332A (ru)
MC (1) MC1628A1 (ru)
NZ (1) NZ210000A (ru)
PH (1) PH21926A (ru)
PL (1) PL144899B1 (ru)
PT (1) PT79416B (ru)
SU (1) SU1371500A3 (ru)
ZA (1) ZA848388B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
GB0613836D0 (en) * 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
GB0800741D0 (en) * 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
GB2471713A (en) * 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
GB2471729A (en) 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2016198878A1 (en) 2015-06-12 2016-12-15 University Of Greenwich Triazine derivatives as interferon-gamma inhibitors
CN109810070B (zh) * 2019-01-29 2022-03-15 太原理工大学 一种含有双酰氧基结构的三嗪酮衍生物及其制备方法和应用
GB202006080D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Cytokine storm syndrome
GB202006076D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Interleukin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759014A (en) * 1952-02-26 1956-10-10 Wellcome Found Improvements in triazines and their manufacture
BG15760A3 (bg) * 1968-06-29 1976-06-21 Неизвестен Метод за получаване на производни на 5-имино- 1, 2, 4- триазина
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DE2003144C3 (de) * 1970-01-24 1980-01-10 Bayer Ag, 5090 Leverkusen 5-Imino-6-alkyl-1^2,4-triazin-Derivate und Verfahren zu deren Herstellung
EP0021120B1 (en) * 1979-06-01 1983-04-06 The Wellcome Foundation Limited 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
CS234018B2 (en) * 1979-06-01 1985-03-14 Wellcome Found Method of 3,5-diammino-6-1,2,4-triazine derivatives making
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
SU1371500A3 (ru) 1988-01-30
KR890000991B1 (ko) 1989-04-15
EP0142306A2 (en) 1985-05-22
GR80723B (en) 1985-02-07
PH21926A (en) 1988-04-08
IL73332A (en) 1988-06-30
HUT36102A (en) 1985-08-28
PL250213A1 (en) 1985-12-03
HU191566B (en) 1987-03-30
ZA848388B (en) 1986-06-25
ES537104A0 (es) 1986-04-16
GB8328757D0 (en) 1983-11-30
CA1261328A (en) 1989-09-26
NZ210000A (en) 1987-08-31
IL73332A0 (en) 1985-01-31
PL144899B1 (en) 1988-07-30
PT79416A (en) 1984-11-01
DK512184A (da) 1985-04-28
FI844212A0 (fi) 1984-10-26
ES8606304A1 (es) 1986-04-16
KR850002964A (ko) 1985-05-28
DK512184D0 (da) 1984-10-26
JPS60109577A (ja) 1985-06-15
MC1628A1 (fr) 1985-09-26
AU564667B2 (en) 1987-08-20
PT79416B (en) 1986-11-13
AU3475884A (en) 1985-05-09
US4649139A (en) 1987-03-10
EP0142306A3 (en) 1986-11-20
FI844212L (fi) 1985-04-28

Similar Documents

Publication Publication Date Title
DD224033A5 (de) Verfahren zur herstellung substituierter 1,2,4-triazine und deren salze
DD151309A5 (de) Verfahren zur herstellung von substituierten aminotriazinen
DD205904A5 (de) Verfahren zur herstellung von imidazo (4,5-c) pyridin-derivaten
EP1228073B1 (de) Imidazolverbindungen als phosphodiesterase vii-hemmer
DE3633861A1 (de) Neue imidazo-benzoxazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE4320157A1 (de) Verwendung von 1,2,4-Dithiazolium-Salzen als Chemotherapeutica
DE3445339C2 (ru)
DE3717080A1 (de) 1-(hydroxystyryl)-5h-2,3-benzodiazepinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2150436A1 (de) Neue organische Verbindungen,ihre Herstellung und ihre Verwendung
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE3405241A1 (de) 1-/4-(benzothia- oder -oxazol-2-ylthio- oder -2-yloxy) phenyl/-1,3,5-triazin-2,4,6-(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3035688C2 (ru)
EP0665228A1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
EP0054873B1 (de) 3,4-Disubstituierte 1,2,5-Oxadiazol-2-oxide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2457309A1 (de) 2-phenylhydrazinothiazolin- beziehungsweise 2-phenylhydrazinothiazininderivate sowie ihre verwendung und verfahren zur herstellung derselben
DE2308883A1 (de) Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
EP0665014B1 (de) 3-Benzoyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen mit anti-arrhythmischer Wirkung
EP1270576B1 (de) 3-Phenyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69028147T2 (de) Antikonvulsive Pirazine
DE2819372A1 (de) 3,5-disubstituierte 1h-1,2,4-triazole und verfahren zu ihrer herstellung
DE2313256B2 (de) 1 ^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3605676C2 (de) Ergolinderivate und deren Säureadditionssalze und deren Verwendung
DE3233380A1 (de) Substituierte pyridyl-cyanoguanidinverbindungen
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel